Why Attend the 17th World Bispecific Summit?
The 17th World Bispecific Summit US brings together the industry's leading experts in antibody discovery, protein engineering, biology, analytical development, developability assessment, and early clinical development to solve the next generation of bispecific and multispecific drug development challenges.
With a focus on bispecific engineering, AI-enabled drug design, novel multispecific formats, co-stimulatory mechanisms, and developability strategies, the summit will showcase the latest scientific advances shaping the future of multi-target therapeutics.
Here's a preview of just some of the sessions already generating excitement among confirmed attendees:
AstraZeneca | Modular Generation of Multispecific Antibodies Using Protein Trans-Splicing
Explore how AstraZeneca is leveraging protein trans-splicing to rapidly generate, screen, and optimise next-generation multispecific antibody formats.Amgen | Advancing Next-Generation TCEs with AI-Guided Drug Design
Discover how AI-guided design is accelerating T-cell engager development and enhancing tumour selectivity.Formerly Bristol Myers Squibb | From Label to Launch: Formulation & CMC Lessons from FDA-Approved Bispecific & Multispecific Antibodies
Gain valuable insights into the formulation, developability, and CMC strategies behind successful approved therapies.Xilio Therapeutics | Unlocking the Potential of Immuno-Oncology Using Masked Bi- & Multispecifics
Learn how masked bi- and multispecifics are being engineered to maximise efficacy while improving safety and tolerability.
As the field continues to evolve, success depends on overcoming mechanistic complexity, molecular differentiation, and clinical translation challenges. This year's agenda is purpose-built to help developers progress the next wave of bispecific and multispecific therapeutics from concept to clinic.
What’s New for 2026?
Attend the Deep Dive Seminar Day
Learn about sophisticated molecular architecture, developability and stability-led engineering to derisk downstream development with Merck, Amgen and Crescent Biopharma
Uncover Novel Targets
Identify first-in-class opportunities and explore mechanistic rationale for different target combinations to maximize therapeutic efficacy with NextPoint Therapeutics, Oxford Biotherapeutics, Oblenio Bio and IN8Bio
Understand Novel Masking & Co-Stimulation Approaches
Understand how novel masking and co-stimulation approaches drive therapeutic activity to improve therapeutic windows with Xilio Therapeutics, EvolveImmune Therapeutics and Rondo Therapeutics
Explore Complex Formats
Examine formats such as logic gated cell engagers and bispecific ADCs to overcome resistance, antigen escape and immune cell exhaustion with AstraZeneca, ImmuVia and ModeX Therapeutics
Modeling & Biomarker Strategies for Bispecifics
Leverage mechanistic modelling for dose selection and navigate future oncology and autoimmune directions for bispecifics using biomarker-led strategies with Takeda, Reverb Therapeutics and Amgen
Gather industry insights
Through discursive panel discussions, cover the trends, data gaps, strengths and weaknesses of the space, as well as data submission package differences for autoimmune versus cancer indications
Explore the Full World Bispecific Summit Agenda
- Get a full overview of the bispecific agenda, speakers, and deep-dive seminar day to plan your attendance efficiently
- Stay ahead of peers with real-world case studies on emerging co-stimulation, masking, and conditional activation approaches
- Gain exclusive insights from panel discussions into industry trends and next-gen bispecific design strategies to keep abreast of the latest innovations
- Easily share with colleagues and decision-makers that are evaluating partners, platforms and competitors to help shape your bispecific pipeline strategy
Brand-New Companies for 2026
Discover the 2026 Agenda
Catch the latest industry breakthroughs, emerging trends and exclusive insights by participating in our dynamic roundtables and panel discussions.
Partner With Us
As the field rapidly expands and matures, position yourself alongside leading solution providers to ensure your brand stands out as a premier choice amid growing competition.
Join Your Community
Immerse yourself in critical conversations with like-minded experts spanning all stages of R&D from target biology, antibody discovery and engineering to developability assessment and clinical development of bispecifics and build invaluable connections.